Leadership at the intersection of health, ethics, technology, and law.

Upcoming
Featured

From The Harvard Crimson: Experts Debate Federal Legalization of Psychedelic Therapy at Harvard Law School Event
Experts on psychedelic use and drug regulation discussed whether psychedelic therapy should be legalized federally. During the event, moderated by former editor-in-chief of Slate Magazine David Plotz, the panelists weighed the benefits of using psychedelics for treating trauma and mood disorders and considered the need for oversight by the U.S. Food and Drug Administration.
Our Focus Areas
Latest
-
What a Psychedelic Church Reveals about Religion and the Law
On Nov. 11, 2024, Bridger Lee Jensen stepped out of his church, Singularism, and was surrounded by police. They detained him, searched the church, and seized an alleged 450 grams of dried psilocybin mushroom.

-
Churches Need to Have a Stance on Psychedelics
Sixty-three percent of Americans identify as Christian. A primary responsibility for the established Christian church is to offer ethical guidance to church members, all of whom live in a society with particular state and federal laws.

-
Psychedelics in Monotheistic Traditions: Between Sacramental Practice and Legal Recognition
Alongside the last two decades of growth in the field of psychedelic medicine, the use of psychedelics in religious and spiritual contexts has increased, not only in novel psychedelic spiritual communities (i.e., psychedelic churches) and indigenous or Native American contexts, but in Abrahamic religious communities as well.

-
Event Recap: What to Expect from the Nascent Negotiations of an International Human Rights Treaty for Older Persons
The case for a new international human rights treaty for older persons is clear. In much of the world, older persons represent ever-larger shares of the population. The World Health Organization estimates the number of people aged over 60 will double by 2050.

-
What We Talk About When We Talk About Psychedelics
One of the biggest challenges in psychedelic regulation is reconciling competing ideas of what psychedelics are and why people use them. These definitions shape not only our cultural narratives but concrete policy choices.


Explore more from our blog
Latest episode of our podcast
Fireside Chat: I. Glenn Cohen and Rochelle Walensky
Professor Glenn Cohen, Faculty Director of the Petrie-Flom Center at Harvard Law School interviews Dr. Rochelle Walensky, 19th Director of the Centers for Disease Control and Prevention and Senior Academic Fellow at the Petrie-Flom Center. They discuss Dr. Walensky’s career as an infectious disease clinician focused on HIV/AIDS, her experience leading the CDC during COVID-19, and her reflections on public health infrastructure in the United States and internationally.






